SRC and lung cancer: These studies showed that AFB1: (i) up-regulates IRS1 and IRS2; (ii) induces Src, Akt and ERK1/2 phosphorylation; (iii) stimulates lung cancer cell migration, which can be inhibited by saracatinib [71].